Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Colorectal Cancer · Liver Metastases · Liver Metastasis Colon Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Amsterdam UMC - location VUmc, Amsterdam, North Holland, Netherlands
Contact: Study coordinator (Danielle J. Vos, MD) · interventieradiologie@amsterdamumc.nl · 020-44571
Contact: Principal Investigator (Martijn R. Meijerink, Prof.)

Study leads

Martijn R. Meijerink, Prof.
Principal Investigator
Amsterdam UMC

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

Liver Metastases · Colorectal Cancer · Anal Canal Cancer

Abroad (travel likely)RecruitingPHASE2

São Paulo, Brazil

SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases

Colorectal Cancer · Liver Metastases

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

The DRAGON 2 Trial

Colorectal Cancer Liver Metastases (CRLM) · Small Future Liver Remnant (FLR)

Abroad (travel likely)Recruiting

New Haven, United States · Clayton, Australia

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States